We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · February 18, 2021

Primary Tumor Resection Plus Chemotherapy vs Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases

Journal of Clinical Oncology

 

Additional Info

Journal of Clinical Oncology
Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial
J. Clin. Oncol 2021 Feb 09;[EPub Ahead of Print], Y Kanemitsu, K Shitara, J Mizusawa, T Hamaguchi, D Shida, K Komori, S Ikeda, H Ojima, H Ike, A Shiomi, J Watanabe, Y Takii, T Yamaguchi, K Katsumata, M Ito, J Okuda, R Hyakudomi, Y Shimada, H Katayama, H Fukuda

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading